Development and Optimization of Therapeutic Analogues of Anti-TNFα Antibody Infliximab
Xiangtao Yu(Second Military Medical University), B.-H. Li(Shanghai University of Medicine and Health Sciences), Shi Hu(Second Military Medical University), H.-J. Wang(Second Military Medical University), L.-F. Wang(Second Military Medical University), Ying Meng(Sir Run Run Shaw Hospital), Changhai Lei(Second Military Medical University), C. Wang(Second Military Medical University), Yanyong Yang(Second Military Medical University), Jian Dong(Minzu University of China), Yuxin Zhang(Second Military Medical University), Y.-F. Shen(Second Military Medical University), Teng‐Fei Li(Second Military Medical University)
Cited by 0
Related Papers
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
|Nature Communications|2019|484
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
|Nature Communications|2020|432
Lysosomal integral membrane protein-2 (LIMP-2/SCARB2) is involved in lysosomal cholesterol export
|Nature Communications|2019|162
ACACA reduces lipid accumulation through dual regulation of lipid metabolism and mitochondrial function via AMPK- PPARα- CPT1A axis
|Journal of Translational Medicine|2024|108